Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: November 2015

IMS Health Forecasts Global Drug Spending to Increase 30 Percent by 2020

Prescription RxDanbury, CT, November 18, 2015 ― More than half of the world’s population will live in countries where medicine use will exceed one dose per person per day by 2020, up from 31 percent in 2005, as the “medicine use gap” between developed and pharmerging markets narrows.

According to new research released today by the IMS Institute for Healthcare Informatics, total spending on medicines will reach $1.4 trillion by 2020 due to greater patient access to chronic disease treatments and breakthrough innovations in drug therapies.

Global spending is forecast to grow at a 4-7 percent compound annual rate over the next five years.

The report, “Global Medicines Use in 2020: Outlook and Implications,” found that total global spend for pharmaceuticals will increase by $349 billion on a constant-dollar basis, compared with $182 billion during the past five years. Continue reading

FDA Takes Action to Protect Consumers from Potentially Dangerous Dietary Supplements

FDA blueWashington, DC, November 18, 2015 ― The U.S. Food and Drug Administration, in partnership with other government agencies, yesterday announced the results of a yearlong sweep of dietary supplements to identify potentially unsafe or tainted supplements.

The sweep resulted in civil injunctions and criminal actions against 117 various manufacturers and/or distributors of dietary supplements and tainted products falsely marketed as dietary supplements. Continue reading

New Seton Hall, Hackensack Medical School Approved for $16.9 Million in Incentives

Roche seton and hackensackTrenton, NJ, November 17, 2015 ― Andrew George reports in NJBIZ that the future medical school of Seton Hall University and the Hackensack University Health Network received approval on November 13 from the state’s Economic Development Authority (EDA) for a 10-year, $16.9 million Grow New Jersey award.

The joint venture, which will be housed on the now-vacant former Roche corporate campus in Nutley and Clifton, was first announced last January.

In June, Seton Hall and Hackensack finalized the terms of their agreement, which calls for creating the first private medical school in the state. Continue reading

CMS Announces $32 Million to Help Get Eligible Children Enrolled in Health Coverage

Kid Mom PharmacistWashington, DC, November 17, 2015 ― The Centers for Medicare & Medicaid Services yesterday announced $32 million in available funds to support efforts to reach out to families with children eligible for Medicaid and the Children’s Health Insurance Program (CHIP) and help get them covered.

The funds will support activities aimed at alerting families to the availability of free or low-cost health coverage under Medicaid and CHIP, identifying children likely to be eligible, and assisting families with the application and renewal process. Medicaid and CHIP provide comprehensive coverage to the nation’s most vulnerable children. Continue reading

Gov. Christie Signs Proclamation Recognizing ‘Get Smart About Antibiotics’ Week 2015

Antibiotics Week Get SmartTrenton, NJ, November 17, 2015 ― Antibiotics are powerful medicines used to combat life-threatening bacterial diseases, but overuse poses significant public health threats.

Get Smart About Antibiotics Week is an annual observance intended to educate the public about proper antibiotic use and prevention of antibiotic-resistant infections across all health care settings.

Gov. Chris Christie signed a proclamation recognizing Nov. 16 – 22 as Get Smart About Antibiotics Week in New Jersey. Continue reading

Medical Innovation: Rutgers Student Led a Team that Built Prosthesis for Little Girl’s Hand

Katherine Lau (SOE '16) Biomedical EngineeringNew Brunswick, NJ, November 16, 2015 ― Carl Blesch reports that Rutgers University student Katherine Lau was looking for a hands-on summer research project.  Yong Dawson was looking for a normal life for her daughter.

Together, they gave 4-year-old Hailey Dawson a gift that doctors could not provide — an affordable, functioning prosthetic hand that can be rebuilt as Hailey grows up.

Hailey, an energetic and inquisitive little girl, was born with Poland syndrome, a birth defect marked by incomplete development of hand and chest muscles typically on a person’s right side. Continue reading

New Federal Report: U.S. Autism Cases Appear to Have Increased in 2014

Autism kid handsWashington, DC, November 16, 2015 ― Ariana Eunjung Cha reports in The Washington Post that the number of autism cases in the United States appeared to jump dramatically in 2014 according to new estimates released November 13.

However, researchers said that changes in the format of the questionnaire likely affected the numbers.

The report from the Centers for Disease Control (CDC) and Prevention and National Center for Health Statistics (NCHS) shows that the prevalence of autism in children ages 3 to 17 went up about 80 percent from 2011-2013 to 2014. Continue reading

CDC Research: Preventable Colon Cancer Deaths Cost the Economy $6.4 Billion

CDC LogoWashington, DC, November 16, 2015 ― Nancy Shute reports on NPR that nearly 20 percent of the people in low-income communities who die of colon cancer could have been saved with early screening.

And those premature deaths take a toll on communities that can least bear it.

Lower-income communities in the United States face $6.4 billion in lost wages and productivity because of premature deaths due to colon cancer, according to researchers at the Centers for Disease Control and Prevention. Continue reading

HHS Announces Forum on Pharmaceutical Innovation, Access, Affordability and Better Health

HHS Logo blueWashington, DC, November 16, 2015 ― The U.S. Department of Health and Human Services yesterday announced a public forum to explore pharmaceutical innovation, access, affordability and better health.

Below is the text of the invitation:

Modern medicine, including new pharmaceuticals that cure or help combat life threatening diseases, continues to deliver significant benefits for patients.  And in general, the development of new, innovative medicines has been good for both patients and our economy.

However, the high and growing cost of drugs has created hardship for families, employers, and states. Specialty medications represent only 1% of all prescriptions but, in 2014, these medications resulted in over 31% of all drug spending. Continue reading

Rutgers Cancer Institute Collaborates with Big Ten Cancer Research Consortium on Clinical Trial for Metastatic Kidney Cancer

Rutgers CINJ LogoNew Brunswick, NJ, November 15, 2015 ― In conjunction with the Big Ten Cancer Research Consortium (BTCRC), Rutgers Cancer Institute of New Jersey has opened a clinical trial for patients with kidney cancer that has spread to other parts of the body (metastatic).

The study, known as BTCRC-GU14-003, is examining a combination of pembrolizumab, a type of drug known as a PD-1 or “checkpoint” inhibitor, with bevacizumab, a therapy that targets blood vessel formation in tumors, for the treatment of patients with metastatic kidney cancer. Continue reading